• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Banco Santander, Lloyds Banking And Other Big Stocks Moving Lower In Monday's Pre-Market Session

    2/5/24 5:21:03 AM ET
    $ALTM
    $BIGC
    $CYTK
    $GRPN
    Major Chemicals
    Industrials
    Computer Software: Prepackaged Software
    Technology
    Get the next $ALTM alert in real time by email

    U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Monday.
    Shares of Banco Santander, S.A. (NYSE:SAN) shares fell sharply during today’s pre-market trading.

    Iranian entities reportedly used accounts at Lloyds Banking Group and Banco Santander to evade U.S. sanctions.

    The Iranian entities, including the Islamic Revolutionary Guard Corps, used the British and Spanish banks to bypass U.S. sanctions, reported the Financial Times on Sunday. The IRGC is a branch of the Iranian Armed Forces and has been designated as a terrorist organization by the U.S.

    Banco Santander shares declined 6.9% to $3.89 in pre-market trading.

    Here are some big stocks recording losses in today’s pre-market trading session.

    • Cytokinetics, Incorporated (NASDAQ:CYTK) shares declined 7.9% to $75.40 in pre-market trading.
    • Groupon, Inc. (NASDAQ:GRPN) shares declined 6.5% to $13.12 in pre-market trading.
    • BigCommerce Holdings, Inc. (NASDAQ:BIGC) shares fell 4.4% to $7.98 in pre-market trading after gaining 2% on Friday. BigCommerce is expected to report its financial results for the fourth quarter, before the opening bell on Feb. 22, 2024.
    • KB Financial Group Inc. (NYSE:KB) shares fell 3.4% to $47.80 in pre-market trading after gaining around 7% on Friday.
    • Topgolf Callaway Brands Corp. (NYSE:MODG) shares declined 3.8% to $13.00 in pre-market trading.
    • Arcadium Lithium plc (NYSE:ALTM) shares fell 3.2% to $4.53 in pre-market trading. Arcadium Lithium is projected to release fourth quarter 2023 earnings results after the closing bell on Feb. 22, 2024.
    • Lloyds Banking Group plc (NYSE:LYG) shares fell 2.4% to $2.06 in pre-market trading. Iranian entities reportedly used accounts at Lloyds Banking Group and Banco Santander to evade U.S. sanctions.

     

    Now Read This: Investor Optimism Improves Following Tech Earnings, Jobs Data; S&P 500 Gains For 4th Week

    Don’t forget to check out our premarket coverage here

    Get the next $ALTM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALTM
    $BIGC
    $CYTK
    $GRPN

    CompanyDatePrice TargetRatingAnalyst
    Banco Santander S.A. Sponsored ADR (Spain)
    $SAN
    3/23/2026Equal-Weight → Overweight
    Morgan Stanley
    Banco Santander S.A. Sponsored ADR (Spain)
    $SAN
    2/23/2026Sector Perform → Outperform
    RBC Capital Mkts
    Cytokinetics Incorporated
    $CYTK
    1/28/2026$87.00Overweight
    Barclays
    Banco Santander S.A. Sponsored ADR (Spain)
    $SAN
    1/13/2026Hold → Buy
    Kepler
    Cytokinetics Incorporated
    $CYTK
    12/18/2025$95.00Neutral → Buy
    Goldman
    Topgolf Callaway Brands Corp.
    $MODG
    10/17/2025$10.00Neutral
    UBS
    Lloyds Banking Group Plc
    $LYG
    10/9/2025Hold → Buy
    Kepler
    Lloyds Banking Group Plc
    $LYG
    8/5/2025Neutral → Buy
    Goldman
    More analyst ratings

    $ALTM
    $BIGC
    $CYTK
    $GRPN
    SEC Filings

    View All

    SEC Form 6-K filed by Lloyds Banking Group Plc

    6-K - Lloyds Banking Group plc (0001160106) (Filer)

    3/27/26 2:30:32 PM ET
    $LYG
    Commercial Banks
    Finance

    SEC Form 425 filed by Banco Santander S.A. Sponsored ADR (Spain)

    425 - Banco Santander, S.A. (0000891478) (Filed by)

    3/27/26 12:48:46 PM ET
    $SAN
    Commercial Banks
    Finance

    SEC Form 6-K filed by Banco Santander S.A. Sponsored ADR (Spain)

    6-K - Banco Santander, S.A. (0000891478) (Filer)

    3/27/26 10:54:02 AM ET
    $SAN
    Commercial Banks
    Finance

    $ALTM
    $BIGC
    $CYTK
    $GRPN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Banco Santander upgraded by Morgan Stanley

    Morgan Stanley upgraded Banco Santander from Equal-Weight to Overweight

    3/23/26 8:22:38 AM ET
    $SAN
    Commercial Banks
    Finance

    Banco Santander upgraded by RBC Capital Mkts

    RBC Capital Mkts upgraded Banco Santander from Sector Perform to Outperform

    2/23/26 8:28:41 AM ET
    $SAN
    Commercial Banks
    Finance

    Barclays resumed coverage on Cytokinetics with a new price target

    Barclays resumed coverage of Cytokinetics with a rating of Overweight and set a new price target of $87.00

    1/28/26 7:16:37 AM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALTM
    $BIGC
    $CYTK
    $GRPN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

    SOUTH SAN FRANCISCO, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that on March 13, 2026 it granted stock options to purchase an aggregate of 8,628 shares of common stock and 5,719 restricted stock units (RSUs) that will be settled in shares of common stock upon vesting to 5 employees, whose employment commenced in February and March 2026 as a material inducement to their employment. The RSUs will vest over 3 years, with 40% of the RSUs vesting on the first anniversary of the applicable grant date, an additional 40% of the RSUs vesting on the second anniversary of the grant date and the final 20% vesting on the third anniversary of th

    3/18/26 4:00:00 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cytokinetics Announces Four Presentations at the American College of Cardiology Annual Scientific Session & Expo

    New Analyses from Three Trials in Obstructive HCM Support Findings from Previously Published Data on MYQORZO™ (aficamten) SOUTH SAN FRANCISCO, Calif., March 16, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced four presentations related to MYQORZO™ (aficamten) at the American College of Cardiology (ACC) Annual Scientific Session & Expo taking place March 28–30, 2026 in New Orleans, LA. Recently approved for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) by the U.S. Food and Drug Administration, European Commission, and the China National Medical Products Administration, MYQORZO is an allosteric and reversible inhibi

    3/16/26 8:00:00 AM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Groupon Launches Board-Level Artificial Intelligence Committee and Appoints Amit Shah to Board of Directors

    Technology executive and AI entrepreneur to chair new committee as Company positions marketplace for the era of agentic commerceChicago, Illinois--(Newsfile Corp. - March 10, 2026) - Groupon, Inc. (NASDAQ:GRPN) today announced the appointment of Amit Shah to its Board of Directors, effective March 10, 2026, and the formation of a dedicated Artificial Intelligence Committee of the Board. Shah, a seasoned technology executive and AI entrepreneur, will serve as the Committee's inaugural Chair.With this action, Groupon becomes one of the first publicly traded consumer marketplaces to establish a board-level committee dedicated to artificial intelligence. The formation of the Committee reflects t

    3/10/26 4:15:00 PM ET
    $APRN
    $FLWS
    $GRPN
    Catalog/Specialty Distribution
    Consumer Discretionary
    Other Specialty Stores
    Advertising

    $ALTM
    $BIGC
    $CYTK
    $GRPN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Blum Robert I

    4 - CYTOKINETICS INC (0001061983) (Issuer)

    3/18/26 5:37:21 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Malik Fady Ibraham

    4 - CYTOKINETICS INC (0001061983) (Issuer)

    3/18/26 5:40:44 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Callos Andrew

    4 - CYTOKINETICS INC (0001061983) (Issuer)

    3/18/26 5:43:50 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALTM
    $BIGC
    $CYTK
    $GRPN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ogunlesi Adebayo O. bought $3,055,995 worth of shares (461,583 units at $6.62) (SEC Form 4)

    4 - Topgolf Callaway Brands Corp. (0000837465) (Issuer)

    6/10/25 5:22:01 PM ET
    $MODG
    Recreational Games/Products/Toys
    Consumer Discretionary

    Director Ogunlesi Adebayo O. bought $2,481,049 worth of shares (383,701 units at $6.47) (SEC Form 4)

    4 - Topgolf Callaway Brands Corp. (0000837465) (Issuer)

    6/6/25 4:29:59 PM ET
    $MODG
    Recreational Games/Products/Toys
    Consumer Discretionary

    EVP & Pres., Callaway Golf Hickey Glenn F. bought $68,600 worth of shares (10,000 units at $6.86) (SEC Form 4)

    4 - Topgolf Callaway Brands Corp. (0000837465) (Issuer)

    5/19/25 6:46:40 PM ET
    $MODG
    Recreational Games/Products/Toys
    Consumer Discretionary

    $ALTM
    $BIGC
    $CYTK
    $GRPN
    Financials

    Live finance-specific insights

    View All

    Groupon Reports Fourth Quarter and Fiscal Year 2025 Results

    North America Q4 Local Revenue +4% and Local Billings +9%North America 2025 Local Revenue +5% and Local Billings +14%Positive Trailing twelve month operating cash flow from continuing operations of $64.5 million and Free Cash Flow of $49.9 millionChicago, Illinois--(Newsfile Corp. - March 10, 2026) - Groupon, Inc. (NASDAQ:GRPN) today announced its financial results for the quarter and year ended December 31, 2025 and provided details on its recent operating progress. The Company filed its Form 10-K with the Securities and Exchange Commission and posted earnings commentary including an updated presentation on its investor relations website (investor.groupon.com)."Our 2025 results represent a

    3/10/26 4:15:00 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Groupon Announces Date for Fourth Quarter and Full Year 2025 Financial Results

    Chicago, Illinois--(Newsfile Corp. - February 25, 2026) - Groupon, Inc. (NASDAQ:GRPN) announced today that it intends to release the company's fourth quarter and full year 2025 financial results after the market closes on Tuesday, March 10, 2026. The company will also host a conference call to answer questions regarding the company's results at 8:00am ET on Wednesday, March 11, 2026. Investors may submit questions by emailing [email protected] webcast of the conference call can be accessed live at investor.groupon.com. A replay of the webcast will be available through the same link following the conference call, along with other published materials.About Groupon Groupon (www.groupon.com) (NAS

    2/25/26 7:00:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Cytokinetics Reports Fourth Quarter 2025 Financial Results and Provides Business Update

    MYQORZO® Approved for Adults with Symptomatic Obstructive HCM in U.S., China and Europe; U.S. Launch Underway with First Prescriptions Dispensed within Days of Drug Availability Supplemental NDA for MAPLE-HCM Submitted to FDA in Q1 2026 Expect to Share Topline Results from ACACIA-HCM in Q2 2026 Company Provides 2026 Financial Guidance;~$1.2 Billion in Cash, Cash Equivalents and Investments as of December 31, 2025 SOUTH SAN FRANCISCO, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) reported a management update and financial results for the fourth quarter and full year of 2025. The company also provided full year 2026 financial guidance. "The fourth qu

    2/24/26 4:00:00 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALTM
    $BIGC
    $CYTK
    $GRPN
    Leadership Updates

    Live Leadership Updates

    View All

    Groupon Launches Board-Level Artificial Intelligence Committee and Appoints Amit Shah to Board of Directors

    Technology executive and AI entrepreneur to chair new committee as Company positions marketplace for the era of agentic commerceChicago, Illinois--(Newsfile Corp. - March 10, 2026) - Groupon, Inc. (NASDAQ:GRPN) today announced the appointment of Amit Shah to its Board of Directors, effective March 10, 2026, and the formation of a dedicated Artificial Intelligence Committee of the Board. Shah, a seasoned technology executive and AI entrepreneur, will serve as the Committee's inaugural Chair.With this action, Groupon becomes one of the first publicly traded consumer marketplaces to establish a board-level committee dedicated to artificial intelligence. The formation of the Committee reflects t

    3/10/26 4:15:00 PM ET
    $APRN
    $FLWS
    $GRPN
    Catalog/Specialty Distribution
    Consumer Discretionary
    Other Specialty Stores
    Advertising

    Babcock & Wilcox Enterprises, Inc. Appoints Dr. Homaira Akbari (Ph.D.) to Board of Directors

    Babcock & Wilcox Enterprises, Inc. (B&W) (NYSE:BW) announced today that Dr. Homaira Akbari (Ph.D.) has been appointed to its Board of Directors, bringing the total to seven members. Dr. Akbari has served on the Board of Directors of over 25 public and private companies, including Veolia Group, a global leader in waste to energy, environmentals and hazardous waste facilities, and Banco Santander (NYSE:SAN). Dr. Akbari brings extensive international leadership experience across medium and large technology companies, including in the energy and finance sectors. She has held senior management roles in Fortune 1000 companies including Microsoft, Thales and Liberty Media, and served as member

    1/27/26 4:30:00 PM ET
    $BW
    $SAN
    Building Products
    Industrials
    Commercial Banks
    Finance

    Cytokinetics and Olympic Gold Medalist Sydney McLaughlin-Levrone Team Up to Raise Awareness of the Whole-Person Impact of Hypertrophic Cardiomyopathy (HCM)

    "On Track with HCM" Features Practical Insights for Managing Everyday Life with the Disease, Inspired by the Experience with HCM of McLaughlin-Levrone's Father, Willie McLaughlin SOUTH SAN FRANCISCO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced the launch of "On Track with HCM," demonstrating the company's long-standing commitment to the HCM community. The campaign features four-time Olympic gold medalist Sydney McLaughlin-Levrone, and her father, three-time all-American track star, Willie McLaughlin, who suffered from the non-obstructive form of hypertrophic cardiomyopathy (HCM) for more than two decades before receiving a heart trans

    1/27/26 8:00:00 AM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALTM
    $BIGC
    $CYTK
    $GRPN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/13/24 10:39:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/6/24 2:12:18 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Groupon Inc.

    SC 13G/A - Groupon, Inc. (0001490281) (Subject)

    11/14/24 6:51:01 PM ET
    $GRPN
    Advertising
    Consumer Discretionary